Osaic Holdings
DMRA

Osaic Holdings’s Damora Therapeutics DMRA Stock Holding History

Osaic Holdings’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26 Buy
+1
New +$24 ﹤0.01% 7914
2021
Q4 		– Sell
-16
Closed -$1K – 7448
2021
Q3 		$1K Hold
16
– – ﹤0.01% 7015
2021
Q2 		$2K Buy
+16
New +$2.18K ﹤0.01% 6700

Other funds holding DMRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

Osaic Holdings's DMRA Position: Q2 2026 in Review

Osaic Holdings opened a new position in Damora Therapeutics (DMRA) in Q2 2026: 1 share worth $26. The stake represents ﹤0.01% of the portfolio and ranks #7914 among its holdings. This is a return to the name: Osaic Holdings previously reported a position in DMRA as recently as Q3 2021.

Osaic Holdings first reported a position in DMRA in Q2 2021 and has held it in 3 quarters since. The position peaked at $2K in Q2 2021. 104 funds tracked by Wall St. Rank hold DMRA as of Q2 2026.

  • Osaic Holdings held 1 share of Damora Therapeutics worth $26 as of Q2 2026.
  • Damora Therapeutics was a new Osaic Holdings position in Q2 2026.
  • Damora Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7914 holding.
  • Osaic Holdings first reported a position in Damora Therapeutics in Q2 2021 and has held it in 3 quarters since.
  • Osaic Holdings's Damora Therapeutics position peaked at $2K in Q2 2021.
  • 104 funds tracked by Wall St. Rank held Damora Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.